ONEMEDNET CORPORATION Increase (Decrease) in Accounts Receivable
ONEMEDNET CORPORATION (ONMD) reported Increase (Decrease) in Accounts Receivable of $169.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-14
- ONEMEDNET CORPORATION increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$33.00K, a 571.43% decline year-over-year.
- ONEMEDNET CORPORATION increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $202.00K, a 494.12% increase year-over-year.
- ONEMEDNET CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$87.00K, a 158.00% decline year-over-year.
- ONEMEDNET CORPORATION increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $328.00K.
- ONEMEDNET CORPORATION increase (decrease) in accounts receivable for fiscal 2023 was $133.00K.
- ONEMEDNET CORPORATION increase (decrease) in accounts receivable for fiscal 2022 was -$73.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$33.00K derived: 10-Q 6 month − S-1/A 3 month · filed 2026-08-14 | $169.00K 10-Q · filed 2026-08-14 | $82.00K derived: sum of 3 quarters · filed 2026-08-14 | $410.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $202.00K S-1/A · filed 2026-07-08 | $115.00K derived: sum of 2 quarters · filed 2026-07-08 | $443.00K derived: sum of 3 quarters · filed 2026-07-08 | $450.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$87.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $241.00K derived: sum of 2 quarters · filed 2026-07-08 | $248.00K derived: sum of 3 quarters · filed 2026-08-14 | $282.00K S-1/A · filed 2026-07-08 | ||
| 2025-09-30 | $328.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $335.00K derived: sum of 2 quarters · filed 2026-08-14 | $369.00K 10-Q · filed 2025-11-14 | $519.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $7.00K derived: 10-Q 6 month − S-1/A 3 month · filed 2026-08-14 | $41.00K 10-Q · filed 2026-08-14 | $191.00K derived: sum of 3 quarters · filed 2026-08-14 | $179.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $34.00K S-1/A · filed 2026-07-08 | $184.00K derived: sum of 2 quarters · filed 2026-07-08 | $172.00K derived: sum of 3 quarters · filed 2026-07-08 | -$6.00K derived: sum of 4 quarters · filed 2026-07-08 | ||
| 2024-12-31 | $150.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $138.00K derived: sum of 2 quarters · filed 2026-07-08 | -$40.00K derived: sum of 3 quarters · filed 2026-07-08 | $61.00K S-1/A · filed 2026-07-08 | ||
| 2024-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$190.00K derived: sum of 2 quarters · filed 2025-11-14 | -$89.00K 10-Q · filed 2025-11-14 | -$42.00K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | -$178.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$77.00K 10-Q · filed 2025-08-13 | -$30.00K derived: sum of 3 quarters · filed 2025-08-13 | -$51.00K derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $101.00K 10-Q · filed 2025-05-14 | $148.00K derived: sum of 2 quarters · filed 2025-05-14 | $127.00K derived: sum of 3 quarters · filed 2025-05-14 | -$1.00K derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $26.00K derived: sum of 2 quarters · filed 2025-04-15 | -$102.00K derived: sum of 3 quarters · filed 2025-04-15 | $133.00K 10-K · filed 2025-04-15 | $132.66K 10-K · filed 2024-04-09 | |
| 2023-09-30 | -$21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | -$149.00K derived: sum of 2 quarters · filed 2024-12-17 | $86.00K 10-Q · filed 2024-12-17 | $67.42K 10-Q · filed 2023-11-20 | -$185.00K derived: sum of 4 quarters · filed 2024-12-17 | |
| 2023-06-30 | -$128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-11 | $107.00K 10-Q · filed 2024-12-11 | -$164.00K derived: sum of 3 quarters · filed 2024-12-11 | |||
| 2023-03-31 | $235.00K 10-Q · filed 2024-12-05 | -$36.00K derived: sum of 2 quarters · filed 2024-12-05 | ||||
| 2022-12-31 | -$271.00K derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | -$73.00K 10-K/A · filed 2024-11-05 | -$72.77K 10-K · filed 2024-04-09 | |||
| 2022-09-30 | $198.00K 8-K/A · filed 2024-11-22 | $88.64K 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |